BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6832387)

  • 21. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term pharmacological treatment of portal hypertension].
    Brůha R; Petrtýl J; Urbánek P; Svestka T; Kaláb M; Marecek Z
    Cas Lek Cesk; 2005; 144 Suppl 1():63-6. PubMed ID: 15981990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate and long-term portal hemodynamic consequences of small-diameter H-graft portacaval shunt.
    Zervos EE; Goode SE; Rosemurgy AS
    J Surg Res; 1998 Jan; 74(1):71-5. PubMed ID: 9536977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical results and hemodynamic changes of portal venous system in transjugular intrahepatic portosystemic stent shunt].
    Wu X; Cao J; Wu X
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):303-6. PubMed ID: 9387710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
    Borie DC; Vaillant JC; Breton S; Hannoun L
    Ann Chir; 1999; 53(10):966-72. PubMed ID: 10670142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models].
    Zhou YB; Leng X; Qi G
    Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):244-7. PubMed ID: 10374550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
    Wu Y; Burns RC; Sitzmann JV
    Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
    Wang CT; Kuang YL; Chen ZP
    Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension].
    Jiang SM; Zhou GW; Shen C; Yan JQ; Wan L; Li QY; Yang WP; Shen BY; Chen H; Peng CH; Li HW
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1699-702. PubMed ID: 19094727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of different infusion volumes on hemodynamics of portal hypertension canines after hemorrhagic shock.
    Li XQ; Dong L; Luo JY
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):571-6. PubMed ID: 15567747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current ascites therapy].
    Ochs A
    Praxis (Bern 1994); 1997 Jan; 86(4):94-7. PubMed ID: 9064726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Edema in liver disease].
    Maekawa H; Toda G
    Nihon Rinsho; 2005 Jan; 63(1):80-4. PubMed ID: 15675322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.